An update on the morphology and molecular pathology of serrated colorectal polyps and associated carcinomas

Abstract

Our understanding of serrated colorectal polyps has increased dramatically over the past two decades and has led to a modern classification scheme for these lesions. Sessile serrated polyps with dysplasia represent the most clinically significant serrated polyp; however, the morphologic heterogeneity of dysplasia in sessile serrated polyps has only recently been recognized and correlated with MLH1 immunohistochemistry. Detailed morphologic analysis of traditional serrated adenomas has led to the recognition of flat and early forms of this polyp. Robust data on the risk of metachronous lesions in patients with serrated polyps are also beginning to emerge. This review will summarize our current understanding of serrated polyps and associated carcinomas with a focus on diagnostic criteria, morphologic heterogeneity, molecular findings, and natural history. Controversial issues in the diagnosis and classification of these polyps are also discussed.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

References

  1. 1.

    Munzy D, Bainbridge M, Chang K, Dinh H, Drummond J, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337.

    Google Scholar 

  2. 2.

    Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, et al. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology. 2015;148:77–87.

    CAS  PubMed  Google Scholar 

  3. 3.

    Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology. 1996;110:748–755.

    CAS  PubMed  Google Scholar 

  4. 4.

    Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65–81.

    PubMed  Google Scholar 

  5. 5.

    Bateman AC, Shepherd NA. UK guidance for the pathological reporting of serrated lesions of the colorectum. J Clin Pathol. 2015;68:585–591.

    PubMed  Google Scholar 

  6. 6.

    East JE, Atkin WS, Bateman AC, Clark SK, Dolwani S, Ket SN, et al. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017;66:1181–1196.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524–537.

    CAS  PubMed  Google Scholar 

  8. 8.

    Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc. 1996;44:8–14.

    CAS  PubMed  Google Scholar 

  9. 9.

    Bettington M, Walker N, Rosty C, Brown I, Clouston A, Wockner L, et al. Critical appraisal of the diagnosis of the sessile serrated adenoma. Am J Surg Pathol. 2014;38:158–166.

    PubMed  Google Scholar 

  10. 10.

    Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107:1315–1329.

    PubMed  PubMed Central  Google Scholar 

  11. 11.

    O’Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491–1501.

    PubMed  Google Scholar 

  12. 12.

    Sethi A, Hanson JA. A morphologic reappraisal of endoscopically but not histologically apparent polyps and the emergence of the overlooked goblet cell–rich hyperplastic polyp. Hum Pathol. 2015;46:1147–1152.

    PubMed  Google Scholar 

  13. 13.

    Hazewinkel Y, López-Cerón M, East JE, Rastogi A, Pellisé M, Nakajima T, et al. Endoscopic features of sessile serrated adenomas: validation by international experts using high-resolution white-light endoscopy and narrow-band imaging. Gastrointest Endosc. 2013;77:916–924.

    PubMed  Google Scholar 

  14. 14.

    IJspeert JEG, Bastiaansen BAJ, van Leerdam ME, Meijer GA, van Eeden S, Sanduleanu S, et al. Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps. Gut. 2016;65:963–970.

    PubMed  Google Scholar 

  15. 15.

    Tadepalli US, Feihel D, Miller KM, Itzkowitz SH, Freedman JS, Kornacki S, et al. A morphologic analysis of sessile serrated polyps observed during routine colonoscopy (with video). Gastrointest Endosc. 2011;74:1360–1368.

    PubMed  Google Scholar 

  16. 16.

    Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58:S3–43.

    Google Scholar 

  17. 17.

    Hewett DG, Kaltenbach T, Sano Y, Tanaka S, Saunders BP, Ponchon T, et al. Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology. 2012;143:599–607.

    PubMed  Google Scholar 

  18. 18.

    Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42:1–10.

    PubMed  Google Scholar 

  19. 19.

    Pai RK, Mojtahed A, Rouse RV, Soetikno RM, Kaltenbach T, Ma L, et al. Histologic and molecular analyses of colonic perineurial-like proliferations in serrated polyps: perineurial-like stromal proliferations are seen in sessile serrated adenomas. Am J Surg Pathol. 2011;35:1373–1380.

    PubMed  Google Scholar 

  20. 20.

    Erlenbach-Wünsch K, Bihl M, Hartmann A, Groisman GM, Vieth M, Agaimy A. Serrated epithelial colorectal polyps (hyperplastic polyps, sessile serrated adenomas) with perineurial stroma: Clinicopathological and molecular analysis of a new series. Ann Diagn Pathol. 2018;35:48–52.

    PubMed  Google Scholar 

  21. 21.

    Agaimy A, Stoehr R, Vieth M, Hartmann A. Benign serrated colorectal fibroblastic polyps/intramucosal Perineuriomas are true mixed epithelial-stromal polyps (hybrid hyperplastic polyp/mucosal perineurioma) with frequent BRAF mutations. Am J Surg Pathol. 2010;34:1663–1671.

    PubMed  Google Scholar 

  22. 22.

    Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, Benerjee T, et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol. 2008;32:21–29.

    PubMed  Google Scholar 

  23. 23.

    Bartman AE, Sanderson SJ, Ewing SL, Niehans GA, Wiehr CL, Evans MK, et al. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer. 1999;80:210–218.

    CAS  PubMed  Google Scholar 

  24. 24.

    Bartley AN, Thompson PA, Buckmeier JA, Kepler CY, Hsu C-H, Snyder MS, et al. Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps. Mod Pathol. 2009;23:169–176.

    PubMed  PubMed Central  Google Scholar 

  25. 25.

    Gonzalo DH, Lai KK, Shadrach B, Goldblum JR, Bennett AE, Downs-Kelly E, et al. Gene expression profiling of serrated polyps identifies Annexin A10 as a marker of a sessile serrated adenoma/polyp. J Pathol. 2013;230:420–429.

    CAS  PubMed  Google Scholar 

  26. 26.

    Kim JH, Rhee Y-Y, Kim K-J, Cho N-Y, Lee HS, Kang GH. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability. APMIS. 2014;122:1187–1195.

    CAS  PubMed  Google Scholar 

  27. 27.

    Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, et al. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut. 2017;66:97–106.

    CAS  PubMed  Google Scholar 

  28. 28.

    Liu C, Walker NI, Leggett BA, Whitehall VL, Bettington ML, Rosty C. Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry. Mod Pathol. 2017;30:1728–1738.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Yang JF, Tang S-J, Lash RH, Wu R, Yang Q. Anatomic distribution of sessile serrated adenoma/polyp with and without cytologic dysplasia. Arch Pathol Lab Med. 2015;139:388–393.

    PubMed  Google Scholar 

  30. 30.

    Sheridan TB, Fenton H, Lewin MR, Burkart AL, Iacobuzio-Donahue CA, Frankel WL, et al. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions “caught in the act.” Am J Clin Pathol. 2006;126:564–571.

    PubMed  Google Scholar 

  31. 31.

    Goldstein NS. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol. 2006;125:132–145.

    PubMed  Google Scholar 

  32. 32.

    Burgess NG, Pellise M, Nanda KS, Hourigan LF, Zanati SA, Brown GJ, et al. Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps. Gut. 2016;65:437–446.

    PubMed  Google Scholar 

  33. 33.

    Cenaj O, Gibson J, Odze RD. Clinicopathologic and outcome study of sessile serrated adenomas/polyps with serrated versus intestinal dysplasia. Mod Pathol. 2018;31:633–642.

    PubMed  Google Scholar 

  34. 34.

    Snover DC, Ahnen DJ, Burt RW, Odze RD. Serrated polyps of the colon and rectum and serrated polyposis. In: WHO Classification of tumors of the digestive system, 4th edition. Bosman FT, Carneiro F, Hruban RH, Theise ND, (Eds.). Lyon: International Agency for Research on Cancer, 2010. p. 160–165.

  35. 35.

    Bettington M, Liu C, Gill A, Walker N, Leggett B, Whitehall V, et al. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions. Histopathology 2019. https://doi.org/10.1111/his.13851.

    PubMed  Google Scholar 

  36. 36.

    Bettington ML, Chetty R. Traditional serrated adenoma: an update. Hum Pathol. 2015;46:933–938.

    PubMed  Google Scholar 

  37. 37.

    Bettington ML, Walker NI, Rosty C, Brown IS, Clouston AD, McKeone DM, et al. A clinicopathological and molecular analysis of 200 traditional serrated adenomas. Mod Pathol. 2015;28:414–427.

    PubMed  Google Scholar 

  38. 38.

    Wiland HO, Shadrach B, Allende D, Carver P, Goldblum JR, Liu X, et al. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum. Am J Surg Pathol. 2014;38:1290–1297.

    PubMed  Google Scholar 

  39. 39.

    Kim K-M, Lee EJ, Kim Y-H, Chang DK, Odze RD. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol. 2010;34:667–675.

    PubMed  Google Scholar 

  40. 40.

    Kim M-J, Lee E-J, Suh J-P, Chun S-M, Jang S-J, Kim DS, et al. Traditional serrated adenoma of the colorectum: clinicopathologic implications and endoscopic findings of the precursor lesions. Am J Clin Pathol. 2013;140:898–911.

    CAS  PubMed  Google Scholar 

  41. 41.

    Fu B, Yachida S, Morgan R, Zhong Y, Montgomery EA, Iacobuzio-Donahue CA. Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol. 2012;138:356–366.

    PubMed  PubMed Central  Google Scholar 

  42. 42.

    Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology. 2005;47:32–40.

    CAS  PubMed  Google Scholar 

  43. 43.

    Tsai J-H, Liau J-Y, Lin Y-L, Lin L-I, Cheng Y-C, Cheng M-L, et al. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis. Mod Pathol. 2014;27:1375–1385.

    CAS  PubMed  Google Scholar 

  44. 44.

    N Kalimuthu S, Serra S, Hafezi-Bakhtiari S, Colling R, Wang LM, Chetty R. Mucin-rich variant of traditional serrated adenoma: a distinct morphological variant. Histopathology. 2017;71:208–216.

    PubMed  Google Scholar 

  45. 45.

    Hiromoto T, Murakami T, Akazawa Y, Sasahara N, Saito T, Sakamoto N, et al. Immunohistochemical and genetic characteristics of a colorectal mucin-rich variant of traditional serrated adenoma. Histopathology. 2018;73:444–453.

    PubMed  Google Scholar 

  46. 46.

    Bettington M, Walker N, Rosty C, Brown I, Clouston A, McKeone D, et al. Serrated tubulovillous adenoma of the large intestine. Histopathology. 2016;68:578–587.

    PubMed  Google Scholar 

  47. 47.

    Hafezi-Bakhtiari S, Wang LM, Colling R, Serra S, Chetty R. Histological overlap between colorectal villous/tubulovillous and traditional serrated adenomas. Histopathology. 2015;66:308–313.

    PubMed  Google Scholar 

  48. 48.

    Chetty R, Hafezi-Bakhtiari S, Serra S, Colling R, Wang LM. Traditional serrated adenomas (TSAs) admixed with other serrated (so-called precursor) polyps and conventional adenomas: a frequent occurrence. J Clin Pathol. 2015;68:270–273.

    PubMed  Google Scholar 

  49. 49.

    Goldman H, Ming S, Hickock DF. Nature and significance of hyperplastic polyps of the human colon. Arch Pathol. 1970;89:349–354.

    CAS  PubMed  Google Scholar 

  50. 50.

    Bettington M, Rosty C, Whitehall V, Leggett B, McKeone D, Pearson S-A, et al. A morphological and molecular study of proposed early forms of traditional serrated adenoma. Histopathology. 2018;73:1023–1029.

    PubMed  Google Scholar 

  51. 51.

    Farris AB, Misdraji J, Srivastava A, Muzikansky A, Deshpande V, Lauwers GY, et al. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol. 2008;32:30–35.

    PubMed  Google Scholar 

  52. 52.

    Chetty R, Bateman AC, Torlakovic E, Wang LM, Gill P, Al-Badri A, et al. A pathologist’s survey on the reporting of sessile serrated adenomas/polyps. J Clin Pathol. 2014;67:426–430.

    PubMed  Google Scholar 

  53. 53.

    Payne SR, Church TR, Wandell M, Rösch T, Osborn N, Snover D, et al. Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. Clin Gastroenterol Hepatol. 2014;12:1119–1126.

    PubMed  Google Scholar 

  54. 54.

    Erichsen R, Baron JA, Hamilton-Dutoit SJ, Snover DC, Torlakovic EE, Pedersen L, et al. Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps. Gastroenterology. 2016;150:895–902.

    PubMed  Google Scholar 

  55. 55.

    Huang CC, Frankel WL, Doukides T, Zhou X-P, Zhao W, Yearsley MM. Prolapse-related changes are a confounding factor in misdiagnosis of sessile serrated adenomas in the rectum. Hum Pathol. 2013;44:480–486.

    PubMed  Google Scholar 

  56. 56.

    Pai RK, Hart J, Noffsinger AE. Sessile serrated adenomas strongly predispose to synchronous serrated polyps in non-syndromic patients. Histopathology. 2010;56:581–588.

    PubMed  Google Scholar 

  57. 57.

    Yokoo H, Usman I, Wheaton S, Kampmeier PA. Colorectal polyps with extensive absorptive enterocyte differentiation: histologically distinct variant of hyperplastic polyps. Arch Pathol Lab Med. 1999;123:404–410.

    CAS  PubMed  Google Scholar 

  58. 58.

    García-Solano J, Pérez-Guillermo M, Conesa-Zamora P, Acosta-Ortega J, Trujillo-Santos J, Cerezuela-Fuentes P, et al. Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma. Hum Pathol. 2010;41:1359–1368.

    PubMed  Google Scholar 

  59. 59.

    Fernando WC, Miranda MS, Worthley DL, Togashi K, Watters DJ, Leggett BA, et al. The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort. Gastroenterol Res Pract. 2014;2014:374926.

    PubMed  PubMed Central  Google Scholar 

  60. 60.

    Liu C, Bettington ML, Walker NI, Dwine J, Hartel GF, Leggett BA, et al. CpG Island Methylation in Sessile Serrated Adenomas Increases With Age, Indicating Lower Risk of Malignancy in Young Patients. Gastroenterology. 2018;155:1362–1365.

    CAS  PubMed  Google Scholar 

  61. 61.

    Cho H, Hashimoto T, Yoshida H, Taniguchi H, Ogawa R, Mori T, et al. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp. Histopathology. 2018;73:672–680.

    PubMed  Google Scholar 

  62. 62.

    Hashimoto T, Tanaka Y, Ogawa R, Mori T, Yoshida H, Taniguchi H, et al. Superficially serrated adenoma: a proposal for a novel subtype of colorectal serrated lesion. Mod Pathol. 2018;31:1588–1598.

    CAS  PubMed  Google Scholar 

  63. 63.

    Sekine S, Ogawa R, Hashimoto T, Motohiro K, Yoshida H, Taniguchi H, et al. Comprehensive characterization of RSPO fusions in colorectal traditional serrated adenomas. Histopathology. 2017;71:601–609.

    PubMed  Google Scholar 

  64. 64.

    Sekine S, Yamashita S, Tanabe T, Hashimoto T, Yoshida H, Taniguchi H, et al. Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma. J Pathol. 2016;239:133–138.

    CAS  PubMed  Google Scholar 

  65. 65.

    Hashimoto T, Yamashita S, Yoshida H, Taniguchi H, Ushijima T, Yamada T, et al. WNT Pathway Gene Mutations Are Associated With the Presence of Dysplasia in Colorectal Sessile Serrated Adenoma/Polyps. Am J Surg Pathol. 2017;41:1188–1197.

    PubMed  Google Scholar 

  66. 66.

    Oh K, Redston M, Odze RD. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol. 2005;36:101–111.

    CAS  PubMed  Google Scholar 

  67. 67.

    Kriegl L, Neumann J, Vieth M, Greten FR, Reu S, Jung A, et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod Pathol. 2011;24:1015–1022.

    CAS  PubMed  Google Scholar 

  68. 68.

    Bond CE, Umapathy A, Ramsnes I, Greco SA, Zhen Zhao Z, Mallitt K-A, et al. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers. Int J Cancer. 2012;130:1567–1576.

    CAS  PubMed  Google Scholar 

  69. 69.

    Borowsky J, Dumenil T, Bettington M, Pearson S-A, Bond C, Fennell L, et al. The role of APC in WNT pathway activation in serrated neoplasia. Mod Pathol. 2018;31:495–504.

    CAS  PubMed  Google Scholar 

  70. 70.

    Murakami T, Mitomi H, Saito T, Takahashi M, Sakamoto N, Fukui N, et al. Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum. Mod Pathol. 2015;28:146–158.

    CAS  PubMed  Google Scholar 

  71. 71.

    Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–857.

    PubMed  Google Scholar 

  72. 72.

    Schreiner MA, Weiss DG, Lieberman DA. Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology. 2010;139:1497–1502.

    PubMed  Google Scholar 

  73. 73.

    Hazewinkel Y, de Wijkerslooth TR, Stoop EM, Bossuyt PM, Biermann K, van de Vijver MJ, et al. Prevalence of serrated polyps and association with synchronous advanced neoplasia in screening colonoscopy. Endoscopy. 2014;46:219–224.

    PubMed  Google Scholar 

  74. 74.

    Anderson JC, Lisovsky M, Greene MA, Hagen C, Srivastava A. Factors Associated With Classification of Hyperplastic Polyps as Sessile Serrated Adenomas/Polyps on Morphologic Review. J Clin Gastroenterol. 2017;52:524–529.

    Google Scholar 

  75. 75.

    Holme Ø, Bretthauer M, Eide TJ, Løberg EM, Grzyb K, Løberg M, et al. Long-term risk of colorectal cancer in individuals with serrated polyps. Gut. 2015;64:929–936.

    PubMed  Google Scholar 

  76. 76.

    Lu F-I, van Niekerk DW, Owen D, Tha SPL, Turbin DA, Webber DL. Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol. 2010;34:927–934.

    PubMed  Google Scholar 

  77. 77.

    Sawhney MS, Farrar WD, Gudiseva S, Nelson DB, Lederle FA, Rector TS, et al. Microsatellite instability in interval colon cancers. Gastroenterology. 2006;131:1700–1705.

    PubMed  Google Scholar 

  78. 78.

    Soong TR, Nayor J, Stachler MD, Perencevich M, Jajoo K, Saltzman JR, et al. Clinicopathologic and genetic characteristics of interval colorectal carcinomas favor origin from missed or incompletely excised precursors. Mod Pathol 2018. https://doi.org/10.1038/s41379-018-0176-6.

    PubMed  Google Scholar 

  79. 79.

    Pohl H, Srivastava A, Bensen SP, Anderson P, Rothstein RI, Gordon SR, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013;144:74–80.

    PubMed  Google Scholar 

  80. 80.

    van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101:343–350.

    PubMed  Google Scholar 

  81. 81.

    Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24–28.

    CAS  PubMed  Google Scholar 

  82. 82.

    Zhao S, Wang S, Pan P, Xia T, Chang X, Yang X, et al. Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis. Gastroenterology. 2019. https://doi.org/10.1053/j.gastro.2019.01.260.

    PubMed  Google Scholar 

  83. 83.

    Li D, Jin C, McCulloch C, Kakar S, Berger BM, Imperiale TF, et al. Association of large serrated polyps with synchronous advanced colorectal neoplasia. Am J Gastroenterol. 2009;104:695–702.

    PubMed  Google Scholar 

  84. 84.

    Gao Q, Tsoi KKF, Hirai HW, Wong MCS, Chan FKL, Wu JCY, et al. Serrated polyps and the risk of synchronous colorectal advanced neoplasia: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:501–509.

    PubMed  Google Scholar 

  85. 85.

    Ng SC, Ching JYL, Chan VCW, Wong MCS, Tang R, Wong S, et al. Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals. Aliment Pharmacol Ther. 2015;41:108–115.

    CAS  PubMed  Google Scholar 

  86. 86.

    Hiraoka S, Kato J, Fujiki S, Kaji E, Morikawa T, Murakami T, et al. The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology. 2010;139:1503–1510, 1510.

    PubMed  Google Scholar 

  87. 87.

    Egoavil C, Juárez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, et al. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives. Gastroenterology. 2017;153:106–112.

    PubMed  Google Scholar 

  88. 88.

    Macaron C, Vu HT, Lopez R, Pai RK, Burke CA. Risk of Metachronous Polyps in Individuals With Serrated Polyps. Dis Colon Rectum. 2015;58:762–768.

    PubMed  Google Scholar 

  89. 89.

    Anderson JC, Butterly LF, Robinson CM, Weiss JE, Amos C, Srivastava A. Risk of Metachronous High- Risk Adenomas and Large Serrated Polyps in Individuals With Serrated Polyps on Index Colonoscopy: Data From the New Hampshire Colonoscopy Registry. Gastroenterology. 2018;154:117–127.

    PubMed  Google Scholar 

  90. 90.

    Bensen SP, Cole BF, Mott LA, Baron JA, Sandler RS, Haile R. Colorectal hyperplastic polyps and risk of recurrence of adenomas and hyperplastic polyps. Polyps Prevention Study. Lancet. 1999;354:1873–1874.

    CAS  PubMed  Google Scholar 

  91. 91.

    Lazarus R, Junttila OE, Karttunen TJ, Mäkinen MJ. The risk of metachronous neoplasia in patients with serrated adenoma. Am J Clin Pathol. 2005;123:349–359.

    PubMed  Google Scholar 

  92. 92.

    Laiyemo AO, Murphy G, Sansbury LB, Wang Z, Albert PS, Marcus PM, et al. Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial. Clin Gastroenterol Hepatol. 2009;7:192–197.

    PubMed  Google Scholar 

  93. 93.

    Pereyra L, Zamora R, Gómez EJ, Fischer C, Panigadi GN, González R, et al. Risk of Metachronous Advanced Neoplastic Lesions in Patients with Sporadic Sessile Serrated Adenomas Undergoing Colonoscopic Surveillance. Am J Gastroenterol. 2016;111:871–878.

    PubMed  Google Scholar 

  94. 94.

    Rosty C, Buchanan DD, Walsh MD, Pearson S-A, Pavluk E, Walters RJ, et al. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol. 2012;36:876–882.

    PubMed  PubMed Central  Google Scholar 

  95. 95.

    IJspeert JEG, Rana SaQ, Atkinson NSS, van Herwaarden YJ, Bastiaansen BaJ, van Leerdam ME, et al. Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis. Gut. 2017;66:278–284.

    CAS  PubMed  Google Scholar 

  96. 96.

    Carballal S, Rodríguez-Alcalde D, Moreira L, Hernández L, Rodríguez L, Rodríguez-Moranta F, et al. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut. 2016;65:1829–1837.

    PubMed  Google Scholar 

  97. 97.

    Melson J, Ma K, Arshad S, Greenspan M, Kaminsky T, Melvani V, et al. Presence of small sessile serrated polyps increases rate of advanced neoplasia upon surveillance compared with isolated low-risk tubular adenomas. Gastrointest Endosc. 2016;84:307–314.

    PubMed  Google Scholar 

  98. 98.

    Glazer E, Golla V, Forman R, Zhu H, Levi G, Bodenheimer HC. Serrated adenoma is a risk factor for subsequent adenomatous polyps. Dig Dis Sci. 2008;53:2204–2207.

    PubMed  Google Scholar 

  99. 99.

    Yoon JY, Kim HT, Hong SP, Kim HG, Kim J-O, Yang D-H, et al. High-risk metachronous polyps are more frequent in patients with traditional serrated adenomas than in patients with conventional adenomas: a multicenter prospective study. Gastrointest Endosc. 2015;82:1087–1093.

    PubMed  Google Scholar 

  100. 100.

    Edelstein DL, Axilbund JE, Hylind LM, Romans K, Griffin CA, Cruz-Correa M, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut. 2013;62:404–408.

    PubMed  Google Scholar 

  101. 101.

    Gala MK, Mizukami Y, Le LP, Moriichi K, Austin T, Yamamoto M, et al. Germline mutations in oncogeneinduced senescence pathways are associated with multiple sessile serrated adenomas. Gastroenterology. 2014;146:520–529.

    CAS  PubMed  PubMed Central  Google Scholar 

  102. 102.

    Buchanan DD, Clendenning M, Zhuoer L, Stewart JR, Joseland S, Woodall S, et al. Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study. Gut. 2017;66:1170–1172.

    CAS  PubMed  Google Scholar 

  103. 103.

    Quintana I, Mejías-Luque R, Terradas M, Navarro M, Piñol V, Mur P, et al. Evidence suggests that germline RNF43 mutations are a rare cause of serrated polyposis. Gut. 2018;67:2230–2232.

    CAS  PubMed  Google Scholar 

  104. 104.

    Yan HHN, Lai JCW, Ho SL, Leung WK, Law WL, Lee JFY, et al. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Gut. 2017;66:1645–1656.

    CAS  PubMed  Google Scholar 

  105. 105.

    Win AK, Walters RJ, Buchanan DD, Jenkins MA, Sweet K, Frankel WL, et al. Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol. 2012;107:770–778.

    PubMed  PubMed Central  Google Scholar 

  106. 106.

    Rosty C, Brosens LA, Dekker E, Nagtegaal ID. Serrated polyposis. In: WHO Classification of Tumours of the Digestive System, 5th Edition. Lyon: International Agency for Research on Cancer, 2019. Forthcoming.

  107. 107.

    Rosty C, Walsh MD, Walters RJ, Clendenning M, Pearson S-A, Jenkins MA, et al. Multiplicity and Molecular Heterogeneity of Colorectal Carcinomas in Individuals With Serrated Polyposis. Am J Surg Pathol. 2013;37:434–442.

    PubMed  PubMed Central  Google Scholar 

  108. 108.

    Vemulapalli KC, Rex DK. Failure to recognize serrated polyposis syndrome in a cohort with large sessile colorectal polyps. Gastrointest Endosc. 2012;75:1206–1210.

    PubMed  Google Scholar 

  109. 109.

    Crowder CD, Sweet K, Lehman A, Frankel WL. Serrated Polyposis Is an Underdiagnosed and Unclear Syndrome: The Surgical Pathologist has a Role in Improving Detection. Am J Surg Pathol. 2012;36:1178–1185.

    PubMed  PubMed Central  Google Scholar 

  110. 110.

    Parry S, Burt RW, Win AK, Aung YK, Woodall S, Arnold J, et al. Reducing the polyp burden in serrated polyposis by serial colonoscopy: the impact of nationally coordinated community surveillance. N Z Med J. 2017;130:57–67.

    PubMed  Google Scholar 

  111. 111.

    Boparai KS, Reitsma JB, Lemmens V, van Os T a. M, Mathus-Vliegen EMH, Koornstra JJ, et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut. 2010;59:1222–1225.

    CAS  PubMed  Google Scholar 

  112. 112.

    Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology. 2013;62:367–386.

    PubMed  Google Scholar 

  113. 113.

    Tuppurainen K, Mäkinen JM, Junttila O, Liakka A, Kyllönen AP, Tuominen H, et al. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol. 2005;207:285–294.

    CAS  PubMed  Google Scholar 

  114. 114.

    Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, et al. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Gastroenterology. 2015;148:88–99.

    CAS  PubMed  Google Scholar 

  115. 115.

    Patil DT, Shadrach BL, Rybicki LA, Leach BH, Pai RK. Proximal colon cancers and the serrated pathway: a systematic analysis of precursor histology and BRAF mutation status. Mod Pathol. 2012;25:1423–1431.

    CAS  PubMed  Google Scholar 

  116. 116.

    Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005;65:6063–6069.

    CAS  PubMed  Google Scholar 

  117. 117.

    Pai RK, Jayachandran P, Koong AC, Chang DT, Kwok S, Ma L, et al. BRAF-mutated, Microsatellitestable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features. Am J Surg Pathol. 2012;36:744–752.

    PubMed  PubMed Central  Google Scholar 

  118. 118.

    Landau MS, Kuan S-F, Chiosea S, Pai RK. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression. Hum Pathol. 2014;45:1704–1712.

    CAS  PubMed  Google Scholar 

  119. 119.

    Rosty C, Williamson EJ, Clendenning M, Walters RJ, Walsh MD, Win AK, et al. Re: Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst 2014;106. https://doi.org/10.1093/jnci/dju180.

    PubMed  Google Scholar 

  120. 120.

    Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn. 2006;8:582–588.

    CAS  PubMed  PubMed Central  Google Scholar 

  121. 121.

    Hinoue T, Weisenberger DJ, Lange CPE, Shen H, Byun H-M, Van Den Berg D, et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 2012;22:271–282.

    CAS  PubMed  PubMed Central  Google Scholar 

  122. 122.

    Ogino S, Kawasaki T, Kirkner GJ, Suemoto Y, Meyerhardt JA, Fuchs CS. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer. Gut. 2007;56:1564–1571.

    CAS  PubMed  PubMed Central  Google Scholar 

  123. 123.

    Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2009;58:90–96.

    PubMed  Google Scholar 

  124. 124.

    Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology. 2005;129:837–845.

    CAS  PubMed  Google Scholar 

  125. 125.

    Farchoukh L, Kuan S-F, Dudley B, Brand R, Nikiforova M, Pai RK. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas. Am J Surg Pathol. 2016;40:1390–1399.

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Rish K. Pai or Christophe Rosty.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pai, R.K., Bettington, M., Srivastava, A. et al. An update on the morphology and molecular pathology of serrated colorectal polyps and associated carcinomas. Mod Pathol 32, 1390–1415 (2019). https://doi.org/10.1038/s41379-019-0280-2

Download citation

Further reading